Adenosine (injection)
آدنوزین (تزریقی)
❤️ Cardiovascular SystemAntiarrhythmic
Market / country: 🇺🇸 USA
Adenocard (US)
🧮 Dose calculator
Paroxysmal supraventricular tachycardia · Regimen source: FDA Adenosine inj. · Dosage and Administration
- • Rapid bolus over 1–2 s followed by a rapid saline flush. If no conversion within 1–2 min: 12 mg; the 12 mg dose may be repeated once. Doses over 12 mg not recommended. FDA Adenosine inj. · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Second- or third-degree AV block or sinus node disease (without a functioning pacemaker); hypersensitivity to adenosine. FDA Adenosine inj. · Contraindications
Formulations
- 3 mg/mL (6 mg/2 mL, 12 mg/4 mL) vial — injection 🇺🇸 USA FDA Adenosine inj. · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Adenosine inj. · Pregnancy
“Teratogenic Effects: Pregnancy Category C: Animal reproduction studies have not been conducted with adenosine; nor have studies been performed in pregnant women.”
- 🤱 BreastfeedingNo data
The source for this drug has no section for this group.
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Adenosine inj. · Pediatric Use
“No controlled studies have been conducted in pediatric patients to establish the safety and efficacy of adenosine injection for the conversion of paroxysmal supraventricular tachycardia (PSVT).”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Adenosine inj. · Geriatric Use
“In general, adenosine injection in geriatric patients should be used with caution since this population may have a diminished cardiac function, nodal dysfunction, concomitant diseases or drug therapy that may alter hemodynamic function and produce severe bradycardia or AV block.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA206778
- DailyMed (FDA label)FDA Adenosine inj.
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDC01EB10
- Darooyab (Iran)Adenosine
🇮🇷 Registered in Iran Darooyab · G-1511/Adenosine
Dosage forms with Iranian generic codes, per Darooyab.
- 01836 · ADENOSINE 3MG/ML (2ML) INJ · فرآورده تزریقی آدنوزین ۳ میلیگرم / میلیلیتر، ۲ میلیلیتر
- 16827 · ADENOSINE 5MG/2ML INJ · فرآورده تزریقی آدنوزین ۵ میلیگرم / ۲ میلیلیتر
- 52364 · ADENOSINE INJECTION PARENTERAL 3 mg/1mL 1 mL · فرآورده تزریقی آدنوزین ۳ میلیگرم / ۱ میلیلیتر ۱ میلیلیتر
- 52365 · ADENOSINE INJECTION PARENTERAL 3 mg/1mL 4 mL · فرآورده تزریقی آدنوزین ۳ میلیگرم / ۱ میلیلیتر ۴ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Adenosine inj. · How SuppliedFDA Adenosine inj. · Dosage and AdministrationFDA Adenosine inj. · ContraindicationsFDA Adenosine inj. · PregnancyFDA Adenosine inj. · Pediatric UseFDA Adenosine inj. · Geriatric UseFDA Adenosine inj. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1511/Adenosine
- Clinical review⚠ Unverified